ROIV · Company research
Roivant Sciences Ltd. Common Shares (ROIV): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd (ROIV) Stock Price Target & Forecast - TradingKey | Roivant Sciences Ltd (ROIV) Stock Price Target & Forecast TradingKey | View source ↗ | TradingKey | Oct 19, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences (ROIV) Stock Looks Fully Priced After A 393% Run - Yahoo Finance | Roivant Sciences (ROIV) Stock Looks Fully Priced After A 393% Run Yahoo Finance | View source ↗ | Yahoo Finance | Oct 19, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences (ROIV) Slips 1.50% to $33.53, Holding Above Key Support - Keltner Channel - https://www.siam.in/ | Roivant Sciences (ROIV) Slips 1.50% to $33.53, Holding Above Key Support - Keltner Channel https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 18, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock forecasts - Yahoo Finance UK | Roivant Sciences Ltd. (ROIV) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance | Roivant Sciences Ltd. (ROIV) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo! Finance Canada | Roivant Sciences Ltd. (ROIV) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? - Stocktwits | Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years - Benzinga | Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years Benzinga | View source ↗ | Benzinga | Oct 12, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo! Finance Canada | Roivant Sciences Ltd. (ROIV) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 11, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock forecasts - Yahoo Finance UK | Roivant Sciences Ltd. (ROIV) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class - Stocktwits | IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV) - Simply Wall Street | How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV) Simply Wall Street | View source ↗ | Simply Wall Street | Oct 7, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences (ROIV) director exercises $4.46 options and sells 17,750 shares. - Stock Titan | Roivant Sciences (ROIV) director exercises $4.46 options and sells 17,750 shares. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Through a stock grant settlement, Frank Torti acquires 40,309 Roivant Sciences (ROIV) shares. - Stock Titan | Through a stock grant settlement, Frank Torti acquires 40,309 Roivant Sciences (ROIV) shares. Stock Titan | View source ↗ | Stock Titan | Oct 3, 2026 | neutral | 0 | 0.6 |
| After exercising $3.85 options, Eric Venker sells shares in Roivant Sciences (ROIV). - Stock Titan | After exercising $3.85 options, Eric Venker sells shares in Roivant Sciences (ROIV). Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| CEO Matthew Gline holds 16.6 million shares after Roivant Sciences (ROIV) withholds 76,171 for taxes. - Stock Titan | CEO Matthew Gline holds 16.6 million shares after Roivant Sciences (ROIV) withholds 76,171 for taxes. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Vesting triggers withholding of 46,879 shares from Roivant Sciences (ROIV) President Mayukh Sukhatme. - Stock Titan | Vesting triggers withholding of 46,879 shares from Roivant Sciences (ROIV) President Mayukh Sukhatme. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance | Roivant Sciences Ltd. (ROIV) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 1, 2026 | neutral | 0 | 0.6 |
| Why Roivant Sciences (ROIV) Stock Is Down Today - Quiver Quantitative | Why Roivant Sciences (ROIV) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 15, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences Ltd. (ROIV)’s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story - Yahoo Finance | Roivant Sciences Ltd. (ROIV)’s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story Yahoo Finance | View source ↗ | Yahoo Finance | Sep 13, 2026 | neutral | 0 | 0.6 |
| Roivant Sciences (ROIV) Stock Rally Leans On Cash As Losses Persist - Simply Wall Street | Roivant Sciences (ROIV) Stock Rally Leans On Cash As Losses Persist Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.